- Retraction Note
- Open access
- Published:
Retraction Note: Silibinin suppresses epithelial–mesenchymal transition in human non-small cell lung cancer cells by restraining RHBDD1
Cellular & Molecular Biology Letters volume 30, Article number: 50 (2025)
The Original Article was published on 09 June 2020
Retraction Note: Cellular & Molecular Biology Letters (2020) 25:36 https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s11658-020-00229-6
The Editor-in-Chief has retracted this article because it contains data that overlaps with data from the following articles [1,2,3,4], the first of which was also published by Cellular & Molecular Biology Letters. In addition, an investigation conducted after the publication of these two articles, which were under consideration by the journal at the same time, found additional signs which raise concerns about the authorship of the two manuscripts and the circumstances of the research presented in them. The Editor-in-Chief therefore no longer has confidence in the results and conclusions presented in this article.
The authors have not replied to correspondence from the Publisher.
References
Wang M, Gao Q, Chen Y, et al. PAK4, a target of miR-9-5p, promotes cell proliferation and inhibits apoptosis in colorectal cancer. Cell Mol Biol Lett. 2019;24:58. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s11658-019-0182-9.
Li Z, Wang F, Zhang S. Retracted: Knockdown of lncRNA MNX1-AS1 suppresses cell proliferation, migration, and invasion in prostate cancer. FEBS Open Bio. 2019;9:851–8. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/2211-5463.12611.
Sheng N, Tan G, You W, et al. MiR-145 inhibits human colorectal cancer cell migration and invasion via PAK4-dependent pathway. Cancer Med. 2017;6(6):1331–40. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/cam4.1029.
Wei Y, Dong J, Li F, Wei Z, Tian Y. Knockdown of SLC39A7 suppresses cell proliferation, migration and invasion in cervical cancer. EXCLI J. 2017;16:1165–76. https://doiorg.publicaciones.saludcastillayleon.es/10.17179/excli2017-690.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Xu, S., Zhang, H., Wang, A. et al. Retraction Note: Silibinin suppresses epithelial–mesenchymal transition in human non-small cell lung cancer cells by restraining RHBDD1. Cell Mol Biol Lett 30, 50 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s11658-025-00728-4
Accepted:
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s11658-025-00728-4